Advertisement BioGaia and Ferring sign new marketing agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

BioGaia and Ferring sign new marketing agreement

BioGaia has signed a new agreement with Ferring Pharmaceuticals under which Ferring acquires exclusive rights to sell BioGaia's Probiotic Drops in Australia, New Zealand and Israel as well as BioGaia's Probiotic tablets in Brazil, Egypt, Greece, Iran, Jordan, Canada, Lebanon, Mexico, Saudi Arabia and Syria.

The drops have already been launched in Spain, Portugal, the Czech Republic and Canada and it is expected that they will be launched in Jordan and Mexico during the first quarter of 2008. Ferring has further exclusive rights to sell BioGaia’s Probiotic Drops in Brazil, Egypt, Greece, Iran, Lebanon, Saudi Arabia and Syria.

Peter Rothschild, president of BioGaia, said: “The agreement means that BioGaia’s brand will be found in a large number of new markets and this is a stepping stone in our efforts to create a global brand for probiotic dietary supplements.”